ImmuPharma plc (AIM:IMM)
London
· Delayed Price · Currency is GBP · Price in GBX 3.500
+0.050 (1.45%)
May 13, 2025, 3:43 PM GMT+1
ImmuPharma Market Cap
ImmuPharma has a market cap or net worth of 17.24 million as of May 13, 2025. Its market cap has increased by 90.34% in one year.
Market Cap
17.24M
Enterprise Value
16.16M
Revenue
-69.96K
Ranking
n/a
PE Ratio
n/a
Stock Price
3.50
Market Cap Chart
Since February 22, 2006, ImmuPharma's market cap has decreased from 36.11M to 17.24M, a decrease of -52.26%. That is a compound annual growth rate of -3.77%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 159.28B |
| GSK plc | 56.88B |
| Haleon | 36.42B |
| Smith & Nephew | 9.45B |
| ConvaTec Group | 5.36B |
| Hikma Pharmaceuticals | 4.31B |
| HUTCHMED (China) | 1.83B |
| Genus | 1.39B |